• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对达来argin治疗颌面部急性化脓性炎症过程疗效的临床实验室评估] (注:dalargin这个词在医学领域没有准确对应的通用中文术语,这里按音译处理为“达来argin”,你可根据实际情况进行修正,如果它是某种特定药物等有固定中文名称则应使用准确名称)

[The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].

作者信息

Bazhanov N N, Ganina S S, Pashutin S B, Ragimov Ch R

出版信息

Sov Med. 1991(7):29-31.

PMID:1948337
Abstract

The data obtained by the authors provide evidence on dalargin effect on immune condition of patients with pyoinfammation of maxillofacial soft tissues. Dalargin administration leads to a rise in T-sensitive lymphocyte subpopulation in all the patients as well as stimulates functional activity of peripheral blood polymorphonuclear neutrophils. Similar results were obtained in vitro with dalargin addition to leukocytic suspension despite the absence of the drug bactericidal activity.

摘要

作者获得的数据为达乐argin对颌面部软组织脓性炎症患者免疫状况的影响提供了证据。使用达乐argin可使所有患者的T敏感淋巴细胞亚群增加,并刺激外周血多形核中性粒细胞的功能活性。尽管达乐argin没有杀菌活性,但在体外将其添加到白细胞悬液中也得到了类似的结果。

相似文献

1
[The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].[对达来argin治疗颌面部急性化脓性炎症过程疗效的临床实验室评估] (注:dalargin这个词在医学领域没有准确对应的通用中文术语,这里按音译处理为“达来argin”,你可根据实际情况进行修正,如果它是某种特定药物等有固定中文名称则应使用准确名称)
Sov Med. 1991(7):29-31.
2
[A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].[对达腊argin治疗颌面部急性化脓性炎症过程疗效的临床实验室评估]
Stomatologiia (Mosk). 1993 Oct-Dec;72(4):22-5.
3
[Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
Stomatologiia (Mosk). 1996;75(2):31-3.
4
[Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].[塔替维菌素在颌面部蜂窝织炎联合治疗中的应用指征]
Stomatologiia (Mosk). 1996;75(4):27-30.
5
[Immunomodulating action of levamisole in the combined treatment of children with odontogenic osteomyelitis of the jaws].
Stomatologiia (Mosk). 1988 Jan-Feb;67(1):69-71.
6
[Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].[使用地巴唑治疗颌面部炎性疾病的临床与实验依据]
Stomatologiia (Mosk). 1982 Jan-Feb;61(1):15-7.
7
[The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
Voen Med Zh. 1999 May;320(5):28-33.
8
[Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].[毒死蜱软膏在颌面部急性牙源性炎症过程联合治疗中的应用]
Stomatologiia (Mosk). 1985 Jan-Feb;64(1):35-7.
9
[The use of netromycin in suppurative maxillofacial surgery in children].
Stomatologiia (Mosk). 1994 Jul-Sep;73(3):68-71.
10
[Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
Vestn Khir Im I I Grek. 1981 Oct;127(10):94-7.